Cargando…
Xentry-Gap19 inhibits Connexin43 hemichannel opening especially during hypoxic injury
Hypoxic injury results in cell death, tissue damage and activation of inflammatory pathways. This is mediated by pathological Connexin43 (Cx43) hemichannel (HC) opening resulting in osmotic and ionic imbalances as well as cytokine production perpetuating the inflammatory environment. Gap19 is an int...
Autores principales: | Coutinho, Frazer P., Green, Colin R., Acosta, Monica L., Rupenthal, Ilva D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7223318/ https://www.ncbi.nlm.nih.gov/pubmed/32318976 http://dx.doi.org/10.1007/s13346-020-00763-y |
Ejemplares similares
-
Intracellular oligonucleotide delivery using the cell penetrating peptide Xentry
por: Coutinho, Frazer P., et al.
Publicado: (2018) -
Connexin therapeutics: blocking connexin hemichannel pores is distinct from blocking pannexin channels or gap junctions
por: Acosta, Monica L., et al.
Publicado: (2020) -
Tonabersat Inhibits Connexin43 Hemichannel Opening and Inflammasome Activation in an In Vitro Retinal Epithelial Cell Model of Diabetic Retinopathy
por: Lyon, Heather, et al.
Publicado: (2020) -
Differential Action of Connexin Hemichannel and Pannexin Channel Therapeutics for Potential Treatment of Retinal Diseases
por: Mat Nor, Mohd N., et al.
Publicado: (2021) -
Orally Delivered Connexin43 Hemichannel Blocker, Tonabersat, Inhibits Vascular Breakdown and Inflammasome Activation in a Mouse Model of Diabetic Retinopathy
por: Mugisho, Odunayo O., et al.
Publicado: (2023)